Search

everythinglearnresearchcommunity

for

Search:↓

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Pexidartinib often causes liver issues and fatigue, especially in women.

Tralokinumab for atopic dermatitis may cause eye issues and skin reactions, needing careful monitoring.

Different oral anticoagulants cause various non-bleeding side effects, so careful monitoring is needed.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Ixekizumab has known and some unexpected side effects.

Reporter characteristics affect detection of hair loss from cancer therapy.

Reporter characteristics affect detection of hair loss from cancer therapy.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Isotretinoin therapy for acne can cause many reversible side effects, mainly mild skin conditions, and patient understanding of these effects can improve treatment adherence.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Certain groups of medications given when leaving the hospital are linked to a higher risk of negative drug reactions within 30 days, especially in older adults with respiratory issues.

Low-dose oral minoxidil effectively treats alopecia but can cause side effects like excess hair growth and fluid retention.

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Paternal drug exposure can harm fertility, pregnancy outcomes, and offspring health, with specific drugs linked to various reproductive issues.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Laser-assisted drug delivery is generally safe with mostly mild side effects.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Avacopan may cause unexpected side effects, so early monitoring is important.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Finasteride toxicity information is limited, poor quality, and biased.